Intelligent BIO Solutions Inc. cash flow statement
In fiscal 2026, Intelligent BIO Solutions Inc.'s operations generated −$11.9m of cash; it spent $125,731 on capital projects, leaving free cash flow of −$12.1m.
Cash flow statement
| Fiscal year | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | −0 | −11 | −3 | −7 | −10 | −10 | −12 |
| Depreciation and amortisation | — | — | 0 | 1 | 1 | 1 | 1 |
| Stock-based pay | — | — | — | 0 | 0 | 0 | 0 |
| Capital spending | — | — | — | — | 0 | 0 | 0 |
| Free cash flow | — | — | — | — | −10 | −10 | −12 |
| Free cash flow after stock pay | — | — | — | — | −10 | −10 | −12 |
| Shares issued | — | 1 | — | — | — | — | — |
| Quarter | 2025 Q1Sept 2024 | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −2,387 | −2,325 | −2,755 | −2,210 | −2,847 | −1,568 | −4,331 | −3,182 |
| Depreciation and amortisation | 242 | 305 | 302 | 244 | 258 | 282 | 290 | 288 |
| Stock-based pay | 202 | 12 | 0 | 12 | 12 | 62 | 12 | 97 |
| Capital spending | — | — | — | — | 70 | 68 | −13 | 0 |
| Free cash flow | — | — | — | — | −2,917 | −1,636 | −4,318 | −3,182 |
| Free cash flow after stock pay | — | — | — | — | −2,929 | −1,697 | −4,330 | −3,280 |
| Shares issued | 35 | 642 | 810 | — | — | — | — | — |
Compare with peers
- Cerenome, Inc. cash flow
- Biomerica Inc cash flow
- Charming Medical Ltd cash flow
- Icecure Medical Ltd. cash flow
- Neuraxis, Inc cash flow
Head to head: CNSY vs INBSBMRA vs INBSINBS vs MCTAICCM vs INBS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies